Trials / Conditions / Still's Disease, Adult-Onset

Still's Disease, Adult-Onset

11 registered clinical trials studyying Still's Disease, Adult-Onset — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Assessment of Macrophage Activation syndromE in STill's Disease in Italy NCT06992505	Swedish Orphan Biovitrum	—
Completed	An Efficacy and Safety Study of GNR-086 (Canakinumab Biosimilar) and Ilaris® in Patients With Adult-onset Stil NCT06497491	AO GENERIUM	Phase 3
Completed	Assessment of Macrophage Activation syndromE in STill's Disease NCT06405152	Swedish Orphan Biovitrum	—
Completed	Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of APB-R3 NCT05715736	Syneos Health	Phase 1
Active Not Recruiting	A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD) NCT05814159	Swedish Orphan Biovitrum	Phase 3
Recruiting	Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's NCT03510442	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	—
Terminated	A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Still's Disease (SJIA and AOSD) NCT03265132	Swedish Orphan Biovitrum	Phase 3
Recruiting	Acostill ( RaDiCo Cohort) (RaDiCo Acostill) NCT05927454	Institut National de la Santé Et de la Recherche Médicale, France	—
Completed	Therapeutic Use of Tadekinig Alfa in Adult-onset Still's Disease NCT02398435	AB2 Bio Ltd.	Phase 2
Recruiting	Glycosylated Ferritin in Macrophagic Activation Syndromes NCT02143986	Brugmann University Hospital	—
Completed	Interleukin-1 Trap to Treat Autoinflammatory Diseases NCT00094900	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	Phase 2